Reasonable Growth, Debt Levels, and a High ROIC Make ASTRAZENECA PLC-SPONS ADR (NASDAQ:AZN) Appealing to Quality Investors.

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if ASTRAZENECA PLC-SPONS ADR (NASDAQ:AZN) is suited for quality investing. Investors should of course do their own research, but we spotted ASTRAZENECA PLC-SPONS ADR showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

Key Considerations for Quality Investors.

• ASTRAZENECA PLC-SPONS ADR has achieved substantial revenue growth over the past 5 years, with a 15.71% increase. This signifies the company's ability to successfully capture market opportunities and generate sustained revenue growth.
• ASTRAZENECA PLC-SPONS ADR demonstrates impressive performance in terms of ROIC excluding cash and goodwill, with a 79.12% ratio. This highlights the company's efficient utilization of capital and its focus on maximizing returns for investors.
• The Debt/Free Cash Flow Ratio of ASTRAZENECA PLC-SPONS ADR stands at 4.81, reflecting the company's prudent capital structure and cash flow dynamics. This ratio highlights the company's ability to generate robust free cash flow relative to its debt obligations.
• The Profit Quality (5-year) of ASTRAZENECA PLC-SPONS ADR stands at 759.0%, highlighting its ability to consistently generate reliable profits. This metric underscores the company's strong business fundamentals and reinforces its position as a financially stable entity.
• ASTRAZENECA PLC-SPONS ADR has consistently achieved strong EBIT growth over the past 5 years, with a 29.65% increase. This underscores the company's effective management of its operating income and suggests a positive outlook for future profitability.
• ASTRAZENECA PLC-SPONS ADR has achieved superior EBIT 5-year growth compared to its Revenue 5-year growth. This demonstrates the company's ability to maximize its profitability through effective cost management and operational strategies.

Zooming in on the fundamentals.

Every day, ChartMill assigns a Fundamental Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various fundamental indicators and properties.

We assign a fundamental rating of 6 out of 10 to AZN. AZN was compared to 196 industry peers in the Pharmaceuticals industry. While AZN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AZN has a decent growth rate and is not valued too expensively.

Our latest full fundamental report of AZN contains the most current fundamental analsysis.

More quality stocks can be found in our Caviar Cruise screen.

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.